28
4M CANCER, INC. Proposal to Ohio Tech Angels Investment Screening Committee 1

Proposal to Ohio Tech Angels Investment Screening Committee 1

Embed Size (px)

Citation preview

1

4M CANCER, INC.

Proposal to Ohio Tech Angels Investment Screening Committee

2

Presentation

Our presentation will explain and justify our request for a $765,000 investment from Ohio Tech Angels’ Fund 2 for our business.

3

About Us

Premier cancer information and technology company

Founded 2009 in Zanesville, OH Founders have combined 100 years

experience in oncology and cosmetic surgery, nursing, exercise physiology and gerontology

4

Our Mission

To increase the awareness of how cancer affects individuals at an increasing rate and decrease morbidity associated with the disease through early detection. We believe that increased availability and understanding within the population will decrease cancer rates and risk while increasing early detection.

5

Our Vision

To become a leader in cancer patient advocacy and hasten the day when all people with disabilities have equal access to cancer-related information.

6

Customer Market

This may lead to Misdiagnoses Non-treatment Lack of

communication between physician and patient

Source: College of Communications on Health Communications.

20%

80%

Cancer Patients

Satisfied

Not Satisfied

7

Target Audience

Therefore our audience will be Physical Model – People with all types of

disabilities. Web site - General public looking for

easy to understand information concerning cancer; its causes and prevention.

Database - Medical-related staff, researchers and educators.

8

Initial Product Offerings

Sample of information that will be found on our web site includes multi-sensory adaptations for:

Audio Closed Captioning Photo Lower Literacy Level Communications

Physical 3D models of the two most prevalent forms of breast cancer.

9

Secondary Product Offering

Cancer-related data will be collected at the start up.

Data will be available in year 2. Ohio Appalachian regions data will be

ready first 1st East-Central, 2nd South-East, 3rd

Southern Expansion into Eastern Kentucky and

West Virginia Starting with breast cancer in men and

women then expansion to other types of cancer

10

Patient #10-9809 Invasive Ductal CarcinomaThe arrow is pointing to cancerous mass

11

Patient #10-9809 Invasive Ductal Carcinoma

•Tumors look like lumps•80% of people with breast cancer have this type of cancer•Avoidance•Early Detection•Ways to treat it include

N.B. – notice simplified language for patients with lower literacy levels

12

Patient #10-9803 Globular CarcinomaArrow is pointing to cancerous mass

13

Patient #10-9803 Globular Carcinoma

•Cancer that feels like a small pea in the breast•10 % of people with breast cancer have this type of cancer•Avoidance•Early Detection•Ways to treat it include…

14

Prototypes

Website http://4mcancerinc.110mb.com/index.ht

ml

Physical Model

Data Samples

15

Data Sample

Traits ID – 09-00041

Gender Male Alcohol Consumption

1 drink per day

Age 69 Smoking/Tobacco

None

Race Asian Drug Use None

Children No Family Cancer History

Father – renal

Income $20-29,999 Breast Feeding n/a

Socioeconomic

Low-Mid Class

Cultures n/a

Education High School BMI 34.0

Yearly Screening

No I/D in Weight None

Insured Yes Diet History None

Notes n/a Serum Ca++ Levels

10.1 ± 1.7 U/ml

16

Production Cycle

Inception

Development

Production

Marketing

Sales

17

Inception

After we established the need for our products we decided on a physical model, a web site, and cancer-related data.

Initial prototype costs were established and web page development began.

After establishing the need, this is the initial offering that will allow us entrance into an untapped and underserviced market.

18

Development

We are proposing development of two physical models and will be contracting with local plastic fabricators for mold development and preparation for mass production.

Simultaneous web page development.

We are collecting and categorizing information for dissemination.

19

Production

Following initial cost for mold development and examination for quality, production can begin with an initial order of 2,160 of the physical models.

Professional focus groups will authenticate web site information.

Web site will go live with active solicitation of advertising and other funding sources for support of the web site.

20

Marketing

By contracting with top 8 medical vendors marketing costs for the physical model will be reduced.

Our marketing dollars will be invested in trade shows, product technology development, and outreach to encatchment areas.

The outreach through our web pages will be worldwide and will support both the physical model and the educational goals.

21

Sales

Number of Units

Price Per Annum

Starting Year 2

Subscribers

180 $1,200 $216,000

Monthly Advertisers

75 $500 $450,000

Monthly Models Sold

180 $249 $573,840

22

Financials – Cash Flow Summary 0%

Payback Period

Discount Rate Year 0 Year 1 Year 2 Year 3 Year 4 Year 5

Total inflows $ 987,840 $ - $ 987,840 $1,282,867

$1,389,817

$1,505,754

$ 1,631,441

Total outflows $(606,295) $ (763,590) $(606,295) $(879,717) $(920,061) $(956,420) $(993,850)

Net cash flow $381,545 $(763,590) $ 381,545 $ 403,150

$ 469,755

$ 549,334 $ 637,591

Cumulative Net cash flow $381,545

$ (763,590) $(382,045) $21,105 $490,860

$1,040,194

$1,677,785

23

Intrinsic Values

The non-financial values are incalculable in terms of lives saved and changed and increase in the quality of life.

24

Risks

Not being able to get product into market

Resellers drop our product Patent research isn’t done properly Sales impacted by new research in

field Our technology doesn’t keep up with

trends

25

Risk Avoidance and Mitigation Research all resellers who can get our

product to market Multiple revenue streams can cover

variances in others Hire qualified patent attorneys Keep abreast of research trends in the

cancer fields Test software as future OS, browsers

are released

26

Conclusion

With our knowledge, research, sales figures and risk analysis 4M Cancer, Inc. is worthy to receive start up funds.

27

Request

We request $765,000 from the Ohio Tech Angels Fund 2 under technology and health for the startup costs of 4M Cancer, Inc.

28

Thank you!